The International Journal of Biomedical Research and Healthcare Innovations (IJBRHI) aims to advance scientific knowledge and promote interdisciplinary research in biomedical sciences, clinical medicine, medical biotechnology, and healthcare innovation.
The journal seeks to provide an international scholarly platform for the dissemination of original research, critical scientific evaluations, and evidence-based developments that contribute to understanding human health, disease mechanisms, diagnostic approaches, and therapeutic interventions.
The journal emphasizes research that connects fundamental biomedical discoveries with clinical applications and emerging healthcare technologies. It encourages investigations addressing significant biomedical challenges, innovative diagnostic and treatment strategies, personalized medicine, disease prevention, and the development of effective healthcare solutions.
The principal objective of the journal is to support scientifically rigorous, methodologically transparent, and ethically responsible research that strengthens biomedical knowledge, facilitates translational applications, and contributes to improvements in healthcare quality and patient outcomes.
The journal considers scholarly contributions across biomedical research, clinical investigation, healthcare technology, and interdisciplinary fields:
Molecular biology, cellular biology, medical biochemistry, molecular pathology, cellular signaling, biomarker discovery, and experimental investigations.
Biotechnology diagnostics, instrumentation, biosensors, biomaterials, tissue engineering, medical devices, and diagnostic innovation.
Clinical investigations, translational medicine, therapeutic evaluation, clinical epidemiology, disease management, and precision health.
Human genetics, functional genomics, genomic medicine, molecular diagnostics, pharmacogenomics, and individualized treatment strategies.
Clinical immunology, immunopathology, host–pathogen interactions, vaccine development, antimicrobial resistance, and disease prevention.
Experimental pharmacology, drug discovery, delivery systems, pharmacokinetics, pharmacodynamics, therapeutic efficacy, and drug safety.
Stem cell research, cellular therapies, regenerative biotechnology, tissue repair, bio-scaffolds, and biological function restoration.
Molecular diagnostics, clinical lab sciences, radiological innovations, medical imaging systems, and point-of-care testing technologies.
Medical informatics, artificial intelligence in clinical decisions, telemedicine, remote patient monitoring, and digital health interventions.
Epidemiology, preventive medicine, population health, healthcare accessibility, health services research, patient safety, and delivery systems.
Neurobiology, neurological disorders, neurodegenerative diseases, neuroimaging, neuropharmacology, and nervous system disease research.
Cancer genetics, molecular oncology, tumor biology, biomarkers, oncological diagnostics, targeted therapies, and immunotherapies.
| Original Research Articles | Investigations presenting original biomedical, clinical, laboratory-based, or healthcare-related research findings. |
| Clinical Research Articles | Studies examining clinical interventions, diagnostic procedures, therapeutic outcomes, or patient-related health concerns. |
| Reviews & Meta-Analyses | Critical narrative evaluations, systematic reviews, and meta-analyses using transparent, reproducible methodologies. |
| Methodological Articles | Contributions describing the development, validation, or evaluation of novel biomedical research methods and technologies. |
| Case Reports | Clinically significant observations offering meaningful diagnostic, therapeutic, or educational insights for health professionals. |
| Short Communications | Concise reports presenting focused scientific findings or preliminary biomedical research developments. |
Manuscripts submitted to the journal should demonstrate scientific originality, methodological rigor, appropriate analytical procedures, and transparent reporting. Studies involving human subjects or animal experimentation must document appropriate IRB approval, informed consent, patient privacy, and clinical trial registration where required.
The journal encourages the use of established reporting guidelines, including CONSORT, STROBE, PRISMA, CARE, and ARRIVE standards. Ethical expectations are informed by ICMJE recommendations and COPE principles.
Ethics Framework: Publication procedures strictly follow COPE principles and ICMJE medical reporting standards to safeguard clinical trial integrity, patient confidentiality, and scientific transparency.
Scholarly Contribution: The International Journal of Biomedical Research and Healthcare Innovations seeks contributions that advance understanding of biological mechanisms, strengthen clinical evidence, evaluate emerging medical technologies, and support responsible innovation in healthcare.